Hanson McClain Advisors »

Leap Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $295 115 2.57
2024-06-30 $239 115 2.08
2024-03-31 $306 115 2.66
2023-12-31 $476 115 4.15
2023-09-30 $158 115 1.38
2023-06-30 $359 115 3.13